NATIONAL INJECTABLE OPIOID AGONIST TREATMENT GUIDELINE

 

CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.

​                                                                                                                      

                                                  CLINICAL GUIDELINE (English)                                                CLINICAL GUIDELINE (French)

​

                                                                                    ​                                     

                                                         OPERATIONAL GUIDANCE (English)                                                  OPERATIONAL GUIDANCE (French)

A synopsis of the Guideline was published in the Canadian Medical Association Journal

A podcast was also produced by C​MAJ, which can be found at the link above.

You can also access the Guideline Development Methodology (as supplied by the authors) here 

SUPPLEMENTAL MATERIALS

• Supervised Consumption Sites vs iOAT | English | French

• Sample Program Expectations | English | French

• Sample Patient Bill of Rights | English | French

• Sample Client Safety Care Plan | English | French

• Sample Treatment Plan | English | French

• Sample Floor Plan | English | French

• Lessons Learned | English | French

• FAQ for Patients and Families | English | French

• Case Studies | English | French

• Sample Diacetylmorphine Titration Pre-Printed Order | English | French

• Sample Hydromorphone Titration Pre-Printed Order | English | French

• Sample Hydromorphone Titration Hospital Pre-Printed Order Package | English | French

• Sample Hydromorphone Maintenance Pre-Printed Order | English | French

• Journal Article: Perspectives of people with opioid use disorder on improving addiction treatments and services (Lachapelle, et al, 2020) | English